Shuanglu Pharmaceutical (002038.SZ) obtained the drug registration certificate for Ibrutinib Capsules.

Zhitong Finance APP News, Shuanglu Pharmaceutical (002038.SZ) announced that the company recently received the "Drug Registration Certificate" for Ibrutinib Capsules (trade name: Xinbojin) approved and issued by the National Medical Products Administration (hereinafter referred to as the "NMPA").